Turkey has started to administer its homegrown COVID-19 vaccine candidate to volunteers at a major hospital in the capital Ankara as part of the jab's Phase 3 clinical trials to compare its efficacy to that of the Chinese-developed CoronaVac shot, the country's top health official announced on July 16.
Despite the success of the ongoing vaccination program, COVID-19 cases are on the rise, but presently there is no need to impose restrictions, Health Minister Fahrettin Koca has said.
Data from the Health Ministry show that the daily virus cases inched up above 6,000 cases over the last couple of days after plateauing to around 5,000 in the past weeks.
Turkey has surpassed a 60 million-dose mark in the number of COVID-19 vaccines administered in its inoculation campaign that began in mid-January.
According to data from the country's Health Ministry, well over 38 million people have been given their first doses of the injection, while more than 18 million people have been fully vaccinated against the deadly virus.